Exosome Diagnostics Inc:企業の製品パイプライン分析

◆英語タイトル:Exosome Diagnostics Inc - Product Pipeline Analysis, 2020 Update
◆商品コード:GDME103113PD
◆発行会社(調査会社):GlobalData
◆発行日:2021年1月
◆ページ数:49
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD1,500 ⇒換算¥192,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD2,250 ⇒換算¥288,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Exosome Diagnostics Inc (Exosome Diagnostics) is a provider of diagnostic solutions. The company develops, designs, manufactures and markets biofluid-based molecular diagnostic tests and products for use in personalized medicine. Exosome Diagnostics’ services comprise miRNA profiling, mRNA profiling, mutation detection, ribonucleic acid (RNA) sequencing (including full RNA seq) and custom assay development services. The company also offers disease detection, diagnosis, treatment and monitoring. Its technology is used in the treatment of brain cancer, prostate cancer, and Alzheimer’s disease. Exosome Diagnostics is headquartered in Waltham, Massachusetts, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Exosome Diagnostics Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Exosome Diagnostics Inc Company Overview
Exosome Diagnostics Inc Company Snapshot
Exosome Diagnostics Inc Pipeline Products and Ongoing Clinical Trials Overview
Exosome Diagnostics Inc – Pipeline Analysis Overview
Exosome Diagnostics Inc – Key Facts
Exosome Diagnostics Inc – Major Products and Services
Exosome Diagnostics Inc Pipeline Products by Development Stage
Exosome Diagnostics Inc Ongoing Clinical Trials by Trial Status
Exosome Diagnostics Inc Pipeline Products Overview
Biofluid Nucleic Acid Kit – Alzheimer’s Disease
Biofluid Nucleic Acid Kit – Alzheimer’s Disease Product Overview
Biofluid Nucleic Acid Kit – Cardiovascular Disease
Biofluid Nucleic Acid Kit – Cardiovascular Disease Product Overview
Biofluid Nucleic Acid Kit – Chronic Kidney Disease
Biofluid Nucleic Acid Kit – Chronic Kidney Disease Product Overview
Biofluid Nucleic Acid Kit – Parkinson’s Disease
Biofluid Nucleic Acid Kit – Parkinson’s Disease Product Overview
Biofluid-Based Molecular Diagnostic Test – Brain Cancer
Biofluid-Based Molecular Diagnostic Test – Brain Cancer Product Overview
BIONIC Liquid Biopsy – Bladder Cancer
BIONIC Liquid Biopsy – Bladder Cancer Product Overview
Diagnostic Assay – Arv7
Diagnostic Assay – Arv7 Product Overview
Diagnostic Assay – Arv7 Clinical Trial
Diagnostic Assay – BRAF
Diagnostic Assay – BRAF Product Overview
Diagnostic Assay – Breast Cancer Signature
Diagnostic Assay – Breast Cancer Signature Product Overview
Diagnostic Assay – IDH1
Diagnostic Assay – IDH1 Product Overview
Diagnostic Assay – Kidney Transplant Rejection
Diagnostic Assay – Kidney Transplant Rejection Product Overview
Diagnostic Test – Parkinson’s Disease
Diagnostic Test – Parkinson’s Disease Product Overview
EGFR 29 Mutation Panel
EGFR 29 Mutation Panel Product Overview
ExoDx Lung(T790M)
ExoDx Lung(T790M) Product Overview
ExoDx Lung(T790M) Clinical Trial
ExoDx Prostate(IntelliScore) – IVD Version
ExoDx Prostate(IntelliScore) – IVD Version Product Overview
ExoDx Prostate(IntelliScore) – IVD Version Clinical Trial
Midi Lung Cancer Panel
Midi Lung Cancer Panel Product Overview
Next-Generation Solid Tumor Mutation Panel
Next-Generation Solid Tumor Mutation Panel Product Overview
Shahky
Shahky Product Overview
Exosome Diagnostics Inc – Key Competitors
Exosome Diagnostics Inc – Key Employees
Exosome Diagnostics Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Exosome Diagnostics Inc, Recent Developments
Oct 10, 2019: Medicare issues final local coverage decision for bio-Techne’s ExoDx Prostate(IntelliScore) Test
Jun 17, 2019: FDA grants breakthrough device designation to Bio-Techne’s ExoDx Prostate IntelliScore (EPI) Test
Jun 13, 2019: Bio-Techne receives approval to offer The ExoDx Prostate Intelliscore (EPI) test in New York State
Sep 18, 2018: Bio-Techne announces publication of data demonstrating additional clinical validation of its EPI Test in European Urology Journal
Jun 13, 2018: Exosome Diagnostics Receives ISO 13485:2016 Certification
May 22, 2018: Exosome Diagnostics Announces Bladder Cancer Surveillance Panel
May 22, 2018: Exosome Diagnostics Announces Bladder Cancer Surveillance Panel
May 17, 2018: Exosome Diagnostics’ Second Prospective Validation Study of EPI to be Highlighted at American Urological Association (AUA) Annual Meeting Press Briefing in San Francisco, CA
May 15, 2018: Exosome Diagnostics Presents Breakthrough Data Highlighting Tumor Derived RNA in Biofluids at the International Society for Extracellular Vesicles in Spain
May 09, 2018: Exosome Diagnostics Continues to Expand Coverage Reach for its EPI Test
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
Exosome Diagnostics Inc Pipeline Products and Ongoing Clinical Trials Overview
Exosome Diagnostics Inc Pipeline Products by Equipment Type
Exosome Diagnostics Inc Pipeline Products by Indication
Exosome Diagnostics Inc Ongoing Clinical Trials by Trial Status
Exosome Diagnostics Inc, Key Facts
Exosome Diagnostics Inc, Major Products and Services
Exosome Diagnostics Inc Number of Pipeline Products by Development Stage
Exosome Diagnostics Inc Pipeline Products Summary by Development Stage
Exosome Diagnostics Inc Ongoing Clinical Trials by Trial Status
Exosome Diagnostics Inc Ongoing Clinical Trials Summary
Biofluid Nucleic Acid Kit - Alzheimer's Disease - Product Status
Biofluid Nucleic Acid Kit - Alzheimer's Disease - Product Description
Biofluid Nucleic Acid Kit - Cardiovascular Disease - Product Status
Biofluid Nucleic Acid Kit - Cardiovascular Disease - Product Description
Biofluid Nucleic Acid Kit - Chronic Kidney Disease - Product Status
Biofluid Nucleic Acid Kit - Chronic Kidney Disease - Product Description
Biofluid Nucleic Acid Kit - Parkinson's Disease - Product Status
Biofluid Nucleic Acid Kit - Parkinson's Disease - Product Description
Biofluid-Based Molecular Diagnostic Test - Brain Cancer - Product Status
Biofluid-Based Molecular Diagnostic Test - Brain Cancer - Product Description
BIONIC Liquid Biopsy - Bladder Cancer - Product Status
BIONIC Liquid Biopsy - Bladder Cancer - Product Description
Diagnostic Assay - Arv7 - Product Status
Diagnostic Assay - Arv7 - Product Description
Diagnostic Assay - Arv7 - Detection of ARv7 in the Plasma of Men with Advanced Metastatic Castrate Resistant Prostate Cancer (MCRP)
Diagnostic Assay - BRAF - Product Status
Diagnostic Assay - BRAF - Product Description
Diagnostic Assay - Breast Cancer Signature - Product Status
Diagnostic Assay - Breast Cancer Signature - Product Description
Diagnostic Assay - IDH1 - Product Status
Diagnostic Assay - IDH1 - Product Description
Diagnostic Assay - Kidney Transplant Rejection - Product Status
Diagnostic Assay - Kidney Transplant Rejection - Product Description
Diagnostic Test - Parkinson's Disease - Product Status
Diagnostic Test - Parkinson's Disease - Product Description
EGFR 29 Mutation Panel - Product Status
EGFR 29 Mutation Panel - Product Description
ExoDx Lung(T790M) - Product Status
ExoDx Lung(T790M) - Product Description
ExoDx Lung(T790M) - Detection of Either the EML4-ALK Gene Rearrangements or the T790M EGFR Mutation in the Plasma of Advanced NSCLC Patients
ExoDx Prostate(IntelliScore) - IVD Version - Product Status
ExoDx Prostate(IntelliScore) - IVD Version - Product Description
ExoDx Prostate(IntelliScore) - IVD Version - A Prospective, Randomized Blinded, Shared Decision Impact Trial of the ExoDx Prostate (IntelliScore), EPI Test, in Men Presenting for Initial Biopsy
ExoDx Prostate(IntelliScore) - IVD Version - Clinical Evaluation of ExoDx Prostate (IntelliScore) in Men with Prior Negative Prostate Biopsy Presenting for a Repeat Biopsy
Midi Lung Cancer Panel - Product Status
Midi Lung Cancer Panel - Product Description
Next-Generation Solid Tumor Mutation Panel - Product Status
Next-Generation Solid Tumor Mutation Panel - Product Description
Shahky - Product Status
Shahky - Product Description
Exosome Diagnostics Inc, Key Employees
Exosome Diagnostics Inc, Subsidiaries
Glossary

★海外企業調査レポート[Exosome Diagnostics Inc:企業の製品パイプライン分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Eddie Stobart Logistics plc:企業の戦略・SWOT・財務情報
    Eddie Stobart Logistics plc - Strategy, SWOT and Corporate Finance Report Summary Eddie Stobart Logistics plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • GoPro, Inc.:戦略・SWOT・企業財務分析
    GoPro, Inc. - Strategy, SWOT and Corporate Finance Report Summary GoPro, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Irving Oil Ltd:企業の戦略的SWOT分析
    Irving Oil Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Toro Energy Ltd (TOE):企業の財務・戦略的SWOT分析
    Toro Energy Ltd (TOE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Revalesio Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary Revalesio Corp (Revalesio) is a developer of novel therapeutics for the treatment of inflammatory diseases. The company conducts research and development activities to develop therapeutics in the areas of respiratory, neuroscience and cardiovascular. Its product pipeline includes drugs targe …
  • Pharm-Olam International Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Pharm-Olam International Ltd (Pharm-Olam) is a contract research organization that offers clinical research services. The organization’s services include clinical trials, medical writing, medical monitoring, regulatory submissions, data management, biostatistics analysis, pharmacovigilance, …
  • Kansas City Power & Light Co:企業の戦略的SWOT分析
    Kansas City Power & Light Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Intercept Pharmaceuticals Inc (ICPT):企業の財務・戦略的SWOT分析
    Intercept Pharmaceuticals Inc (ICPT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Blueberry Therapeutics Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Blueberry Therapeutics Ltd (Blueberry Therapeutics) is a provider of nano medicines for the treatment of dermatological disorders. Its pipeline product portfolio includes BB2603-NCE, developed to treat onychomycosis and associated tinea pedis; BB2312 used for the treatment of Acne diseases, …
  • SEAKR Engineering, Inc.:企業の戦略・SWOT・財務情報
    SEAKR Engineering, Inc. - Strategy, SWOT and Corporate Finance Report Summary SEAKR Engineering, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • SteadyMed Therapeutics Inc:医療機器:M&Aディール及び事業提携情報
    Summary SteadyMed Therapeutics Inc (SteadyMed), a subsidiary of SteadyMed Ltd is a pharmaceutical company that develops and commercializes therapeutic product candidates. The company provides patchpump, a customizable, pre-filled, and pre-programmed disposable parenteral delivery platform for large …
  • PT Perusahaan Gas Negara (Persero) Tbk (PGAS):石油・ガス:M&Aディール及び事業提携情報
    Summary PT Perusahaan Gas Negara (Persero) Tbk (PGN) is a downstream energy that transmits and distributes natural gas. The company plans, constructs and develops downstream natural gas businesses and carries out processing, transportation, storage and trading of natural gas. It produces, trades and …
  • Werner Enterprises, Inc. (WERN):企業の財務・戦略的SWOT分析
    Werner Enterprises, Inc. (WERN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Nexen Energy ULC:石油・ガス:M&Aディール及び事業提携情報
    Summary Nexen Energy ULC (Nexen Energy), formerly Nexen Inc., a subsidiary of CNOOC Limited, is an upstream oil and gas company that discovers and develops energy resources. It is involved in the production of conventional oil and gas, oil sands, and shale gas. The company’s activities include explo …
  • Crescita Therapeutics Inc (CTX)-製薬・医療分野:企業M&A・提携分析
    Summary Crescita Therapeutics Inc (Crescita Therapeutics) develops products for the treatment of skin diseases and their symptoms. The company’s product portfolio includes over-the-counter and prescription products such as topical creams. It offers pliaglis, a local anesthetic cream for superficial …
  • Extendicare Inc.:企業の戦略・SWOT・財務分析
    Extendicare Inc. - Strategy, SWOT and Corporate Finance Report Summary Extendicare Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • CPI Aerostructures, Inc.:企業の戦略・SWOT・財務情報
    CPI Aerostructures, Inc. - Strategy, SWOT and Corporate Finance Report Summary CPI Aerostructures, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Avebe U.A.:企業の戦略的SWOT分析
    Avebe U.A. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Tokuyama Corp (4043):企業の財務・戦略的SWOT分析
    Tokuyama Corp (4043) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Voyager Therapeutics Inc (VYGR):製薬・医療:M&Aディール及び事業提携情報
    Summary Voyager Therapeutics Inc (Voyager) is a clinical-stage gene therapy company that develops treatments for patients suffering from severe neurological diseases. The company provides treatment for adeno-associated virus gene therapy field by selecting, designing and manufacturing vectors. Its c …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆